Gastric pH, sevelamer hydrochloride and omeprazole

Clinical Nephrology

Volumn 64, Issue 4, 2005, Pages 320-322

  Capitanini, A ^a   Lupi, A ^a   Osteri, F ^a   Petrone, I ^a   Del Corso, C ^a   Straniti, M ^a   Gallieni, M ^b   Rossi, A ^a  

^a Civil Hospital   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

Gastric pH; Omeprazole; Phosphate binding; Sevelamer hydrochloride

Indexed keywords

CALCITRIOL; OMEPRAZOLE; PHOSPHATE; SEVELAMER;

ADULT; ALKALINIZATION; ARTICLE; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; DRUG CROSS REACTIVITY; DRUG DOSE REDUCTION; DYSPEPSIA; FEMALE; FOLLOW UP; GASTRITIS; HEMODIALYSIS PATIENT; HUMAN; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; STOMACH FUNCTION DISORDER; STOMACH PH;

EID: 26844544501     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64320     Document Type: Article

References (6)

1. Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J 2004 Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification. Clin Nephrol 62: 104-115
2. Janssen MJ, Van der Kuy A, Ter Wee PM, Van Boven WP 1996 Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Clin Nephrol 45: 111-119
3. Rosenbaum DP, Holmes-Farley SR, Mandeville WH, Pitruzzello M, Goldberg DI 1997 Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats. Nephrol Dial Transplant 12: 961-964
4. Ross EA, Scott WE III, Odukale AA, Batich CD 2004 Acid exposure increases sevelamer HCI phosphate binding [Abstract F-PO963]. JASN 15: 275A
5. Sherrard DJ 1991 Aluminium: Much ado about something. N Engl J Med 324: 558-559
6. Slatopolsky EA, Burke SK, Dillon MA 1999 RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 55: 299-307